AztreonamThird Party Manufacturing in India

Aztreonam is a synthetic bactericidal antibiotic that represents the first member of the monobactam class of beta-lactams. It works by selectively binding to penicillin-binding proteins (PBPs), with a high and specific affinity for PBP-3 of susceptible aerobic Gram-negative bacteria. Penicillin-binding proteins are essential enzymes involved in the final transpeptidation step of bacterial cell wall peptidoglycan synthesis. By inhibiting PBP-3, aztreonam prevents the cross-linking of peptidoglycan chains, disrupting the structural integrity of the bacterial cell wall and resulting in cell elongation, lysis, and cell death. Due to its unique monocyclic beta-lactam ring structure, aztreonam is highly resistant to hydrolysis by many beta-lactamase enzymes, including metallo-beta-lactamases and cephalosporinases, making it effective against multi-drug resistant Gram-negative pathogens. However, it lacks activity against Gram-positive bacteria and anaerobes because it does not bind to their respective PBPs. Unlike other bicyclic beta-lactams, such as penicillins and cephalosporins, aztreonam exhibits minimal cross-reactivity with their respective antibodies, allowing it to be used safely as an alternative therapy in patients with a history of severe penicillin allergies.

Therapeutic Uses

Aztreonam is indicated for the treatment of severe infections caused by susceptible aerobic Gram-negative bacteria:

• Urinary Tract Infections (UTIs): It is highly effective for complicated and uncomplicated UTIs, including pyelonephritis.
• Lower Respiratory Tract Infections: It is used to treat nosocomial pneumonia and bronchopulmonary infections.
• Septicemia and Intra-Abdominal Infections: It is prescribed for systemic bloodstream infections and peritonitis, often co-administered with other antibiotics to provide broad-spectrum cover.
• Skin, Bone, and Soft Tissue Infections: It targets deep-seated tissue infections caused by Pseudomonas aeruginosa or Enterobacteriaceae.

Why Manufacturers Choose Aztreonam

Aztreonam is a high-demand, high-value monobactam antibiotic, particularly critical for patients allergic to penicillins. Its effectiveness against resistant Gram-negative strains makes it a staple in intensive care and hospital settings. The market for aztreonam injection (1g and 2g vials) is robust, especially in export markets across the Middle East, Latin America, and Southeast Asia. Manufacturing aztreonam requires dedicated sterile dry-powder injection filling facilities to prevent cross-contamination and ensure quality. Indian WHO-GMP certified manufacturers provide contract manufacturing of sterile aztreonam vials under strict international quality guidelines, offering excellent export opportunities.

This makes Aztreonam one of the most sought-after antibiotic injection molecules for third party manufacturing in India, with consistent demand from hospital distributors and export-oriented pharmaceutical companies.